ALKEM
1950.05
2019-01-04
Alkem Laboratories Ltd
Profitability metrics STANDALONE CONSOLIDATED
Asset Turnover 0.7576 0.8053
Current ratio 2.36 2.3
WC days 143.93 154.33
EBITDA (%) 20.26 17.39
FCF (Rs Cr.) -15 0
ROCE (%) 17.78 16.62
ROE (%) 14.66 12.97

Solvency metrics STANDALONE CONSOLIDATED
Cash Ratio 0.18 0.27
Div. payout (%) 21.71 24.64
Int. Coverage 30.19 17.71
LT D/E 0.11 0.21
Solvency Ratio 1.5 0.78

Valuation STANDALONE CONSOLIDATED
Beta 0 0
Div. yield (%) 1 1
EV (Rs Cr.) 23904.7 24056.2
P/BV 4.84 4.86
P/E 33.01 37.46
PEG 0.77 0.88
P/S 4.46 3.68

Balance sheet metrics STANDALONE CONSOLIDATED
BV/share 408.62 406.86
3Y growth BV/s (%) 58 62
Cash (Rs Cr.) 278.3 576.78
Total Debt (Rs Cr.) 548 998
Net block (Rs Cr.) 1471 2284

P&L metrics STANDALONE CONSOLIDATED
DPS 13 13.01
EPS 59.89 52.78
Net Income (Rs Cr.) 716 631
Operating profit (Rs Cr.) 992 1029
No. of o/s shares 11.955 11.955
Revenue (Rs Cr.) 5300 6422
Total Income (Rs Cr.) 5382 6518

Cash Flow metrics STANDALONE CONSOLIDATED
CEPS (%) 2660 2309
3Y growth CEPS 0.32 -0.16
CFF (Rs Cr.) -60 85
CFI (Rs Cr.) -273 -361
CFO (Rs Cr.) 318 276
FCF (Rs Cr.) -15 0
3Y growth Op. CF (%) 32 -16

Growth metrics STANDALONE CONSOLIDATED
3Y growth dividends (%) 50 275
1Q growth EBITDA (%) 0 0
3Y growth EBITDA (%) 81 67
4Q growth EBITDA (%) 0 0
1Q growth EPS (%) 0 0
3Y growth EPS (%) 63 36
4Q growth EPS (%) 0 0
3Y growth Net inc. (%) 63 36
1Y growth Op. CF (%) -36 -25
1Q growth revenue (%) 0 0
3Y growth revenue (%) 67 70
4Q growth revenue (%) 0 0